logo
Q1 earnings, FII activity among 7 factors that may impact D-Street action this week

Q1 earnings, FII activity among 7 factors that may impact D-Street action this week

Economic Times13-07-2025
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
2. Domestic data:
3. Global events:
4. IPO action:
6. Technical factors:
Markets drifted lower during the week and lost over a per cent, primarily pressured by the lingering uncertainty surrounding global tariffs and a disappointing start to the earnings season.While the tone remained largely stable in the first three sessions, profit booking in the final sessions dragged the indices lower. Eventually, both the Nifty and Sensex settled near their weekly lows at 25,149.85 and 82,500.47, respectively.Nifty slipped below its crucial short-term moving average—the 20-day EMA—and has entered the previous consolidation range of 24,500–25,200. This breakdown has disrupted the positive bias, potentially leading to extended consolidation.'On the downside, the 24,500–24,900 zone will act as a key support area, while on the upside, 25,550 remains a critical hurdle in the event of a rebound, with major resistance at 25,750,' said Ajit Mishra – SVP, Research at Religare Broking.Here are the key factors that will likely impact the D-Street action next week:Looking ahead, the earnings season will be in full focus. A packed calendar includes results from HCL Tech JSW Steel , L&T Finance, and HDFC Bank , among others.On the macroeconomic front, participants will closely track the WPI and CPI inflation data scheduled for July 14 for further cues on the economy.Globally, uncertainty around potential tariff moves by the Trump administration continues to weigh on sentiment, but optimism has risen around an early trade deal between US-India.A busy IPO calendar with several prominent listings like Crizan Ltd and Glen Industries, and many more in the pipeline is likely to keep the Indian market busy.The trend in foreign institutional investor (FII) flows will also be closely monitored. On Friday, foreign institutional investors (FIIs) were net sellers at Rs 5,155.68 crore, while the domestic institutional investors (DIIs) were net buyers at Rs 3,482.95 crore.The Nifty continues to remain weak as the index slipped below the previous swing low on the hourly chart. Additionally, it has fallen below the 21 EMA on the daily timeframe. Momentum also remains weak in the short term, with the RSI in a negative crossover. However, after the recent decline, the index has approached the support of the 200-hourly moving average.'A move above 25,150-25,160 in the initial trading hour could trigger a rally towards 25,250 and 25,400. On the downside, support is placed at 25,090 and 24,900,' said Rupak De, Senior Technical Analyst at LKP Securities.Rupee traded weak by 0.11% at 85.73 as capital market weakness, along with higher Gold and Silver prices and weak global cues, weighed on sentiment. The rise in tariffs from the US on Brazil and Canada has added uncertainty, and markets will remain cautious until constructive trade talks emerge.Additionally, the dollar index has shown recovery, rising from 96.50 to 97.75, which has added pressure on emerging market currencies. Rupee is expected to trade in a range of 85.25 to 86.20.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Share price under Rs 200: Multibagger railway stock secured over Rs 1600 crore order last week
Share price under Rs 200: Multibagger railway stock secured over Rs 1600 crore order last week

Indian Express

time25 minutes ago

  • Indian Express

Share price under Rs 200: Multibagger railway stock secured over Rs 1600 crore order last week

Multibagger railway stock order win: A multibagger railway PSU stock secured back-to-back orders last week, according to exchange filings. The total value of these new contracts exceeds Rs 1,600 crore. Can you guess which one? Here's a hint – as of July 20 (NSE data), this railway company has a market capitalisation of Rs 17,563.19 crore. This railway company is none other than IRCON International Limited. IRCON is a navratna company under the Ministry of Railways. Last week (July 14-18), IRCON bagged three new orders. These are as follows: In an exchange filing on July 18, the company said, 'Mumbai Metropolitan Region Development Authority has awarded the work to Ircon International Limited for CA-233, Line-6, Package-2: Design, Manufacture, Supply, Installation, Integration, Testing and Commissioning of Power Supply and Traction, E & M, Lifts & Escalators including 5 Years of Comprehensive Maintenance after 2 Years of Defect Liability Maintenance Period of Line 6 [Swami Samarth Nagar to Vikhroli (EEH)] of Mumbai Metro Rail Project of MMRDA.' The project cost is Rs 642,44,02,451.34. In a separate filing, the railway company said, ' Mumbai Metropolitan Region Development Authority has awarded the work to Ircon International Limited for CA-239, Line-5, Package-2: Design, Manufacture, Supply, Installation, Integration, Testing And Commissioning of 220 kV receiving Substation Including 220 kV, 33kV & 25kV Cabling Work, Complete 25kV Overhead Catenary System along with switching station, 33kV Auxiliary Power Distribution System Including 33/0.415 kV Auxiliary Sub-Station (ASS) And Complete SCADA System, Electrical and Mechanical works, Lift & Escalator Works for part of Main Line, Stations & Kasheli Depot of Mumbai Metro Rail Line 5 Project of MMRDA Including 5 Years of Comprehensive Maintenance after 2 Years of Defect Liability and Maintenance Period.' The project cost is Rs 471,29,72,820. In a filing on Friday, the company said, ' IRCON has been awarded with Letter of Award for the project floated by RVNL (Participated in this bid in JV mode with M/s JPWIPL (i.e., IRCON – 70% & JPIWL – 30%).' Here the total project amount is Rs 755,78,21,993.63 (IRCON Share – Rs 529,04,75,395.53),' the company said. Shares of IRCON closed in red on Friday (July 18). The PSU railway stock settled at Rs 186.74 apiece, down 1.60 per cent on NSE. IRCON International Limited is a component of the BSE 500. According to the BSE analytics (as of July 20), shares of IRCON gave negative returns in the last 1 week and 2 weeks, by 2.20 per cent and 6.27 per cent, respectively. Shares of the PSU railway stock also fell in the last 1 year by 40.25 per cent. However, in the past 2 years, 3 years, and 5 years, shares of the company rose 116.15 per cent, 405.27 per cent, and 307.03 per cent, respectively. This year, IRCON paid a dividend of Rs 1.65 in February. Last year, the PSU railway stock declared total dividends of Rs 3.10. IRCON issued bonuses in the ratio of 1:1 for the equity shareholders.

Anthem Biosciences IPO: What GMP signals ahead of listing on Monday
Anthem Biosciences IPO: What GMP signals ahead of listing on Monday

Economic Times

time25 minutes ago

  • Economic Times

Anthem Biosciences IPO: What GMP signals ahead of listing on Monday

Anthem Biosciences is set to debut on the stock exchanges on Monday, July 21. In the unlisted market, its shares are trading at a premium of Rs 165–170, indicating a potential listing gain of around 29% over the IPO price of Rs 570 (upper band). ADVERTISEMENT While the grey market premium (GMP) reflects strong investor interest, it remains a speculative indicator and can change quickly before listing. The Rs 3,395 crore IPO was entirely an offer for sale (OFS) and closed on July 16. It witnessed robust demand, with an overall subscription of 67.42 times. The Qualified Institutional Buyers (QIB) segment was subscribed 192.80 times, Non-Institutional Investors (NII) 44.70 times, and the retail portion 5.98 times. The issue was priced in a band of Rs 540–570 per share, with a minimum lot size of 26 shares. The stock will list on both NSE and BSE. Founded in 2006, Anthem Biosciences operates in a niche segment of the pharma value chain, offering end-to-end drug discovery, development, and manufacturing services. It is among the few Indian CRDMOs with integrated capabilities across both small molecules (chemical-based) and large molecules (biologics).Its differentiated fee-for-service (FFS) model has enabled it to cater to small and mid-sized biotech firms globally, which constitute a large portion of its client base. Since its inception, the company has served over 675 clients and completed more than 8,000 projects. ADVERTISEMENT In FY25, Anthem reported strong financials, with an EBITDA margin of 36.8% and a Return on Net Worth (RoNW) of 20.8%. As of March 2025, the company's net worth stood at Rs 2,410 facilities are cGMP-compliant and approved by global regulatory bodies such as the USFDA, ANVISA, TGA, and PMDA. The company is currently expanding its fermentation and synthesis capacities to meet growing demand for complex biologics and specialty ingredients. ADVERTISEMENT JM Financial is the book-running lead manager of the Anthem Biosciences IPO, while Kfin Technologies is the registrar for the issue. (Disclaimer: Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)

July 22–25: Critical time windows could trigger Nifty reversals, says Harshubh Shah
July 22–25: Critical time windows could trigger Nifty reversals, says Harshubh Shah

Economic Times

time25 minutes ago

  • Economic Times

July 22–25: Critical time windows could trigger Nifty reversals, says Harshubh Shah

Indian equity markets closed lower for the third straight week, with the Nifty50 slipping 0.7% to end below the 25,000 mark for the week ending July 18, 2025.A sharp uptick in foreign institutional investor (FPI) selling has amplified the weakness. According to NSDL data, FPIs have offloaded Indian equities worth Rs 10,775 crore so far in beneath the surface of price action, a subtler force is at work: time. July 15–19: Time Levels Guide Market Moves In our previous analysis, we highlighted July 15 as a pivotal date—and the market respected this projection. On Friday, July 19, once the low of July 15 was breached, the Nifty witnessed aggressive selling. Even the high made on July 15 proved significant: a failed breakout attempt near that level on July 16 triggered fresh declines. Critical support zones worked well last week: 24,978 acted as a crucial support level before Friday's 25,085 mark (July 15's low) also played a vital role, as its breach led to a steep again, the market demonstrated that both price levels and time zones matter in short-term trading decisions. Precision in Time-Based Analysis: Intraday Accuracy Unmatched Throughout the week, time analysis proved its merit with remarkable precision. Specific intraday time slots consistently aligned with swing highs, lows, and key reversals: July 14: 10:20 AM – Swing high, followed by a downtrend 11:30 AM – Day's low formed near this time July 15: 9:45 AM – Day's low formed 2:45 PM – Swing low marked with precision July 16–18: Multiple intraday pivots around key time slots like 10:45 AM, 12:30 PM, and 2:45 PM Such consistency confirms that Time Analysis, when combined with Price Action, can provide traders with clear, actionable insights. Outlook for July 21–25: Big Moves ExpectedKey Support Zones: 24,978 / 24,850 / 24,676 / 24,538 / 24,450 Key Resistance Levels: 25,080 / 25,147 / 25,320 / 25,434 / 25,566 / 25,600 Intraday Time Slots to Watch: Key Dates to Track July 22–23: Expect swift intraday moves — ideal for short-term traders and 24–25: Watch for a potential top or bottom formation. Positional traders should stay alert. Conclusion While many traders focus solely on chart patterns, indicators, or news flow, the underlying rhythm of Time remains a powerful yet underappreciated tool. The coming week holds key signals hidden in specific time windows. Stay prepared — sharp moves could catch the unprepared off-guard. (The author is Director, Wealthview Analytics Pvt Ltd. SEBI Registration – INH000009676) (Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of The Economic Times)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store